Nota Bene Cancer
Nota Bene Cancer est un bulletin hebdomadaire de veille bibliographique. En libre accès, Nota Bene Cancer permet à ses abonnés de gagner du temps pour se tenir informé de l’actualité scientifique et médicale dans les divers domaines de la recherche sur les cancers.
Rechercher des publications
Pour retrouver les publications signalées par Nota Bene Cancer (archives indexées à partir du n°127 du 1" mars 2012) :
Sommaire du n° 617 du 23 septembre 2024
Qualité de vie, soins de support (4)
Mené sur 187 patients atteints d'un cancer et présentant une cachexie (poumon non à petites cellules, pancréas, côlon-rectum), cet essai randomisé de phase II évalue l'efficacité, du point de vue de l'évolution du poids à 12 semaines, du ponségromab (un anticorps inhibant la cytokine GDF-15)
Ponsegromab for the Treatment of Cancer Cachexia
Mené sur 187 patients atteints d'un cancer et présentant une cachexie (poumon non à petites cellules, pancréas, côlon-rectum), cet essai randomisé de phase II évalue l'efficacité, du point de vue de l'évolution du poids à 12 semaines, du ponségromab (un anticorps inhibant la cytokine GDF-15)
Ponsegromab for the Treatment of Cancer Cachexia
John D. Groarke ; Jeffrey Crawford ; Susie M. Collins ; Shannon Lubaczewski ; Eric J. Roeland ; Tateaki Naito ; Andrew E. Hendifar ; Marie Fallon ; Koichi Takayama ; Timothy Asmis ; Richard F. Dunne ; Isik Karahanoglu ; Carrie A. Northcott ; Magdalena A. Harrington ; Michelle Rossulek ; Ruolun Qiu ; Aditi R. Saxena
Background: Cachexia is a common complication of cancer and is associated with an increased risk of death. The level of growth differentiation factor 15 (GDF-15), a circulating cytokine, is elevated in cancer cachexia. In a small, open-label, phase 1b study involving patients with cancer cachexia, ponsegromab, a humanized monoclonal antibody inhibiting GDF-15, was associated with improved weight, appetite, and physical activity, along with suppressed serum GDF-15 levels. Methods: In this phase [...]
NEJM at ESMO — Ponsegromab in Cancer Cachexia
Mené sur 187 patients atteints d'un cancer et présentant une cachexie (poumon non à petites cellules, pancréas, côlon-rectum), cet essai randomisé de phase II évalue l'efficacité, du point de vue de l'évolution du poids à 12 semaines, du ponségromab (un anticorps inhibant la cytokine GDF-15)
NEJM at ESMO — Ponsegromab in Cancer Cachexia
Eric J. Rubin ; Oladapo O. Yeku ; Stephen Morrissey
In this audio interview, Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research being presented at the 2024 European Society of Medical Oncology annual meeting.
Menée aux Etats-Unis auprès de 4 944 patients ayant survécu à un cancer de la prostate, cette étude transversale analyse l'association entre l'indice de masse corporelle et la pratique d'une activité physique
Association between body mass index and physical activity among prostate cancer survivors
Menée aux Etats-Unis auprès de 4 944 patients ayant survécu à un cancer de la prostate, cette étude transversale analyse l'association entre l'indice de masse corporelle et la pratique d'une activité physique
Association between body mass index and physical activity among prostate cancer survivors
Haiderbhai, Shabbir ; Sahmoun, Abe E.
Purpose: We assessed the associations between (1) body mass index (BMI) and participating in any physical activities (PAs) in past 30 days and (2) cancer and behavioral-related variables and participating in any PAs in past 30 days among prostate cancer (PCa) survivors. Methods: We conducted a cross-sectional analysis of data from the 2018–2022 Behavioral Risk Factor Surveillance System. Multivariable weighted logistic regression was used to examine the associations. Results: Of the 4944 PCa [...]
Ce dossier thématique fait le point sur la sexualité des patients atteints d'un cancer hématologique ou ayant survécu à la maladie
Sexual health-related psychological and emotional life after allogeneic haematopoietic stem-cell transplantation
Ce dossier thématique fait le point sur la sexualité des patients atteints d'un cancer hématologique ou ayant survécu à la maladie
Sexual health-related psychological and emotional life after allogeneic haematopoietic stem-cell transplantation
Alsuliman, Tamim ; Alasadi, Lugien ; Polomeni, Alice ; Capes, Antoine ; Peric, Zinaida ; Linke, Andrea ; Schoemans, Helene ; Malard, Florent ; Chalandon, Yves ; Mohty, Mohamad
Sexual health is important for the quality of life of patients who have received haematopoietic stem-cell transplantation (HSCT). Sexual dysfunction and couple dissatisfaction can seriously affect a patient's recovery and treatment process. However, this aspect of post-transplantation recovery is still usually neglected in clinical practice. In this Series paper, we aim to elucidate the emotional and psychosocial factors affecting the sexual function in these patients, with a special focus on [...]
Sexually transmitted infections in the context of haematological malignancies
Ce dossier thématique fait le point sur la sexualité des patients atteints d'un cancer hématologique ou ayant survécu à la maladie
Sexually transmitted infections in the context of haematological malignancies
Alsuliman, Tamim ; Musiu, Paolo ; Stocker, Nicolas ; Desnica, Lana ; El-Cheikh, Jean ; Sestili, Simona ; Srour, Micha ; Marjanovic, Zora ; Alrstom, Ali
Sexually transmitted infections (STIs) are a difficult health challenge for immunocompromised patients. Patients treated for several haematological malignancies have further compromised immune systems. Furthermore, many chemotherapies, alone or associated with haematopoietic stem-cell transplantation, make the body's natural barriers extremely fragile. STIs can negatively impact both patient morbidity and mortality. In this Series paper, we discuss Chlamydia trachomatis, Neisseria gonorrhoeae, [...]
Sexual health and emotional wellbeing of adolescent and young adult survivors of haematological malignancies
Ce dossier thématique fait le point sur la sexualité des patients atteints d'un cancer hématologique ou ayant survécu à la maladie
Sexual health and emotional wellbeing of adolescent and young adult survivors of haematological malignancies
Alsuliman, Tamim ; Rojas, Reyes María Martín ; Basha, Ahmad Ali ; Musiu, Paolo ; Magro, Léonardo ; Testi, Anna Maria ; Mohty, Mohamad
This Comment is linked to The Lancet Haematology Series on Sexual Health in Patients with Haematological Malignancies; we discuss sexual and emotional life for patients with haematological malignancies elsewhere in our Series. Cancer, the side effects of cancer therapies, and changes in body image are often traumatic long-term events for cancer survivors (ie, individuals no longer being treated for cancer and considered to have no active disease), especially for adolescent and young adult (AYA) [...]
Sexual health and emotional wellbeing of patients with haematological malignancies: general review
Ce dossier thématique fait le point sur la sexualité des patients atteints d'un cancer hématologique ou ayant survécu à la maladie
Sexual health and emotional wellbeing of patients with haematological malignancies: general review
Alsuliman, Tamim ; Rojas, Reyes María Martín ; Moukalled, Nour ; Brissot, Eolia ; Quarez-Blaise, Laurence ; Marjanovic, Zora ; Blaise, Didier ; Murphy, Danielle ; Logue, Melissa ; Savani, Bipin N. ; Mohty, Mohamad
Sexual health is an important aspect of a person's life. Many patients and haematologists believe that intimacy and sexuality issues are substantial during cancer treatment. The haematological cancer disease, diagnosis, shock of the announcement, treatment, and follow-up appointments, can all have negative effects on the quality of life of patients, their partners, other family members, and friends. Addressing the intimate aspects of patients' lives not only enhances their wellbeing but also [...]
Let's talk about sex and haematopoietic stem-cell transplantation
Ce dossier thématique fait le point sur la sexualité des patients atteints d'un cancer hématologique ou ayant survécu à la maladie
Let's talk about sex and haematopoietic stem-cell transplantation
Linke, Andrea ; del Castillo, Jacqueline ; Scheffel, Kirsti ; Feenstra, Peter ; Manninen, Riikka-Leena
When diagnosed with a life-threatening disease, the last thing you want to talk about is sex. Wrong. Sexual health is crucial to wellbeing and quality of life. Yet, in our experience, sex remains a taboo topic in haematology and is rarely discussed openly.
Mené au Japon sur 162 patientes atteintes d'un cancer du sein HER2+ ou surexprimant faiblement HER2, cet essai de phase II évalue l'intérêt d'un triplet à base d'olanzapine pour prévenir les nausées et vomissements induits par le trastuzumab déruxtécan
A randomized, double-blind, placebo-controlled phase II study of olanzapine based prophylactic antiemetic therapy for delayed and persistent nausea...
Mené au Japon sur 162 patientes atteintes d'un cancer du sein HER2+ ou surexprimant faiblement HER2, cet essai de phase II évalue l'intérêt d'un triplet à base d'olanzapine pour prévenir les nausées et vomissements induits par le trastuzumab déruxtécan
A randomized, double-blind, placebo-controlled phase II study of olanzapine based prophylactic antiemetic therapy for delayed and persistent nausea and vomiting in patients with HER2-positive or HER2-low breast cancer treated with trastuzumab deruxtecan: ERICA study (WJOG14320B)
Sakai, H. ; Tsurutani, J. ; Ozaki, Y. ; Ishiguro, H. ; Nozawa, K. ; Yamanaka, T. ; Aogi, K. ; Matsumoto, K. ; Iwasa, T. ; Tokiwa, M. ; Tsuneizumi, M. ; Miyoshi, Y. ; Kitazawa, C. ; Yamamoto, M. ; Takano, Y. ; Imamura, C. K. ; Chiba, Y. ; Takiguchi, D. ; Ezumi, T. ; Takano, T.
Background: Nausea and vomiting are common adverse events associated with trastuzumab deruxtecan (T-DXd). We evaluated the efficacy of an olanzapine-based triplet regimen for preventing nausea and vomiting in patients receiving first cycle T-DXd. Patients and methods: This multi-institutional, randomized, double-blind, placebo-controlled (ERICA) phase II study enrolled patients with HER2-positive/HER2-low metastatic breast cancer receiving their first cycle of T-DXd. Patients were randomized to [...]
Observation (2)
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée à la COVID-19
Education and Information to Improve Adherence to Screening for Breast, Colorectal, and Cervical Cancer—Lessons Learned during the COVID-19 Pandemic
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée à la COVID-19
Education and Information to Improve Adherence to Screening for Breast, Colorectal, and Cervical Cancer—Lessons Learned during the COVID-19 Pandemic
Gabriele, Raimondo ; Campagnol, Monica ; Sapienza, Paolo ; Borrelli, Valeria ; Di Marzo, Luca ; Sterpetti, Antonio V.
The objective of this study was to determine the correlation between adherence to cancer screening programs and earlier diagnosis of the 14 most common types of cancers in the adult population, before and during the COVID-19 pandemic. National data concerning number of admissions and operations in Italy for adult patients admitted with oncologic problems during the COVID-19 pandemic (2020 to 2022) and in the pre-pandemic period (2015 to 2019) were analyzed. We selected 14 types of cancer that [...]
The COVID-19 pandemic and associated declines in cancer incidence by race/ethnicity and census-tract level SES, rurality, and persistent poverty st...
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée à la COVID-19
The COVID-19 pandemic and associated declines in cancer incidence by race/ethnicity and census-tract level SES, rurality, and persistent poverty status
Liu, Benmei ; Yu, Mandi ; Byrne, Jeffrey ; Cronin, Katheen A. ; Feuer, Eric J.
Background: The COVID-19 pandemic had a significant impact on cancer screening and treatment, particularly in 2020. However, no single study has comprehensively analyzed its effects on cancer incidence and disparities among groups such as race/ethnicity, socioeconomic status (SES), persistent poverty (PP), and rurality. Methods: Utilizing the recent data from the United States National Cancer Institute's Surveillance, Epidemiology, and End Results Program, we calculated delay- and age-adjusted [...]
Impact of the COVID-19 pandemic on treatment of patients with acute myeloid leukaemia in India
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée à la COVID-19
Impact of the COVID-19 pandemic on treatment of patients with acute myeloid leukaemia in India
Philip, Chepsy ; Selvarajan, Sushil ; Nayak, Lingaraj ; Jain, Hasmukh ; Kulkarni, Uday ; Samuel, Prasanna ; Agrawal, Narendra ; Kayal, Smita ; Mishra, Kundan ; Pavitra, D. S. ; Jayachandran, P. K. ; Bala, Stalin Chowdary ; Raghavan, Vineetha ; Paul, Mobin ; Singh, Jagdeep ; Sreeraj, V. ; Mujumdar, Swaratika ; Nayak, Akshatha ; Prakash, Om ; Barath, U. ; Dharmaraj, Aravind ; Rajendra, Akhil ; Thorat, Jayashree ; Bagal, Bhausaheb ; Abraham, Aby ; Bhurani, Dinesh ; Ganesan, Prasanth ; Sengar, Manju ; Mathews, Vikram
During the COVID-19 pandemic, our findings highlight changes in AML management strategies in India. There was a decrease in overall patient registrations, particularly at large referral centers, while smaller centers saw an increase, reflecting a shift towards more localized care. This shift was accompanied by a rise in the use of hypomethylating agents (HMAs). Despite these changes, survival outcomes remained comparable to pre-pandemic levels, likely due to improved infection control measures [...]
Menée au Royaume-Uni sur la période 2000-2021, cette étude de cohorte analyse l'évolution de la prévalence et de l'incidence du cancer de la prostate ainsi que de la survie
Incidence, Prevalence, and Survival of Prostate Cancer in the UK
Menée au Royaume-Uni sur la période 2000-2021, cette étude de cohorte analyse l'évolution de la prévalence et de l'incidence du cancer de la prostate ainsi que de la survie
Incidence, Prevalence, and Survival of Prostate Cancer in the UK
Tan, Eng Hooi ; Burn, Edward ; Barclay, Nicola L. ; Delmestri, Antonella ; Man, Wai Yi ; Golozar, Asieh ; Serrano, Àlvar Roselló ; Duarte-Salles, Talita ; Cornford, Philip ; Prieto Alhambra, Daniel ; Newby, Danielle ; OPTIMA Consortium
Importance : Incidence, prevalence, and survival are pertinent measures to inform the management and provision of prostate cancer care. Objective : To calculate the incidence, prevalence, and survival rates for prostate cancer in the UK from 2000 to 2021. Design, Setting, and Participants : This population-based cohort study uses routinely collected primary care data from the UK. Male patients aged 18 years or older with at least 1 year of history registered in Clinical Practice Research [...]
Approches psycho-sociales (3)
A partir d'une revue systématique de la littérature (9 études, 1 305 patients), cette méta-analyse identifie les facteurs associés au risque de déficiences cognitives chez les patients atteints d'un cancer du poumon
Risk factors for cancer-related cognitive impairment among individuals with lung cancer: a systematic review and meta-analysis
A partir d'une revue systématique de la littérature (9 études, 1 305 patients), cette méta-analyse identifie les facteurs associés au risque de déficiences cognitives chez les patients atteints d'un cancer du poumon
Risk factors for cancer-related cognitive impairment among individuals with lung cancer: a systematic review and meta-analysis
Ye, Lei ; Xu, Xiaoyu ; Qi, Wei ; Chen, Fangmei ; Xia, Guanghui
Objectives: Cancer-related cognitive impairment (CRCI) exerts a negative impact on the quality of life in lung cancer survivors. Risk factors for CRCI in lung cancer patients remain unclear.This study aimed to identify risk factors for CRCI in lung cancer patients. Methods: A comprehensive literature search was conducted across PubMed, CINAHL, Web of Science, Wanfang, VIP Database, Embase, and China National Knowledge Infrastructure (CNKI) from their inception until March 10, 2024. Studies were [...]
Menée en Suède à partir de données portant sur 1 801 890 témoins et 180 189 hommes atteints d'un cancer de la prostate diagnostiqué entre 1998 et 2017, cette étude de cohorte analyse le risque de développer des symptômes d'anxiété en lien avec la maladie ou ses traitements
Risk of Anxiety Disorders in Men With Prostate Cancer: A National Cohort Study
Menée en Suède à partir de données portant sur 1 801 890 témoins et 180 189 hommes atteints d'un cancer de la prostate diagnostiqué entre 1998 et 2017, cette étude de cohorte analyse le risque de développer des symptômes d'anxiété en lien avec la maladie ou ses traitements
Risk of Anxiety Disorders in Men With Prostate Cancer: A National Cohort Study
Crump, Casey ; Stattin, Pär ; Brooks, James D ; Sundquist, Jan ; Sundquist, Kristina ; Sieh, Weiva
Background: Men with prostate cancer (PC) may experience significant psychosocial distress from physical symptoms, treatment side effects, or fear of recurrence. However, little is known about the long-term risk of anxiety disorders in men with PC. Methods: A national cohort study was conducted of 180,189 men diagnosed with PC during 1998-2017 and 1,801,890 age-matched population-based control men in Sweden. Anxiety disorders were ascertained from nationwide outpatient and inpatient records [...]
Mené sur 120 aidants de patients atteints d'une tumeur cérébrale primitive, cet essai randomisé évalue l'intérêt d'une intervention psychosociale pour réduire leurs symptômes d'anxiété et de dépression
NeuroCARE: A Randomized Controlled Trial of a Psychological Intervention for Caregivers of Patients With Primary Malignant Brain Tumors
Mené sur 120 aidants de patients atteints d'une tumeur cérébrale primitive, cet essai randomisé évalue l'intérêt d'une intervention psychosociale pour réduire leurs symptômes d'anxiété et de dépression
NeuroCARE: A Randomized Controlled Trial of a Psychological Intervention for Caregivers of Patients With Primary Malignant Brain Tumors
Deborah A. Forst ; Alyx F. Podgurski ; Sumita M. Strander ; Jessica D. Whitman ; Shibani Datta ; Kedie Pintro ; Nora K. Horick ; Kelcie D. Willis ; Timothy S. Sannes ; Joseph A. Greer ; Areej El-Jawahri ; Jamie M. Jacobs ; Jennifer S. Temel
Purpose: Caregivers of patients with primary malignant brain tumors (PMBT) experience significant psychological distress. We assessed the effect of a psychological intervention (NeuroCARE) on anxiety symptoms among PMBT caregivers. Methods: We conducted a randomized trial of NeuroCARE versus usual care in PMBT caregivers with elevated anxiety (Generalized Anxiety Disorder-7 score ≥5) within 6 months of the patient's diagnosis. NeuroCARE was developed for PMBT caregivers and consists of six [...]
Caring for the Family Caregiver in Oncology
Mené sur 120 aidants de patients atteints d'une tumeur cérébrale primitive, cet essai randomisé évalue l'intérêt d'une intervention psychosociale pour réduire leurs symptômes d'anxiété et de dépression
Caring for the Family Caregiver in Oncology
Liv Mendelsohn ; Rinat Nissim ; Breffni Hannon
Across all health care settings, the crucial role played by family caregivers (FCs) is often overlooked. FCs are defined as relatives, friends, or neighbors who provide unpaid patient care, assisting with physically, emotionally, and socially demanding tasks.1 With medical advancements that have extended the lives of many patients with cancer and with most cancer care now being delivered in outpatient settings, the responsibilities placed on FCs have become increasingly complex and prolonged. [...]
Analyses économiques et systèmes de soins (1)
A partir d'une revue systématique de la littérature (7 essais randomisés), cette étude compare l'efficacité et les coûts de stratégies antiémétiques à base d'aprépitant et de traitements de type NEPA (nétupitant-palonosétron) avec dexaméthasone pour prendre en charge des nausées et vomissements induits par la chimiothérapie
Comparative effectiveness of netupitant-palonosetron plus dexamethasone versus aprepitant-based regimens in mitigating chemotherapy-induced nausea...
A partir d'une revue systématique de la littérature (7 essais randomisés), cette étude compare l'efficacité et les coûts de stratégies antiémétiques à base d'aprépitant et de traitements de type NEPA (nétupitant-palonosétron) avec dexaméthasone pour prendre en charge des nausées et vomissements induits par la chimiothérapie
Comparative effectiveness of netupitant-palonosetron plus dexamethasone versus aprepitant-based regimens in mitigating chemotherapy-induced nausea and vomiting: a meta-analysis of randomized controlled trials
Luo, Wun-Ting ; Chang, Chia-Lun ; Huang, Tsai-Wei ; Gautama, Made Satya Nugraha
Background: Despite guidelines for managing chemotherapy-induced nausea and vomiting (CINV), there remains a need to clarify the optimal use of neurokinin-1 (NK1) receptor antagonists. Comparing the effectiveness of NEPA (netupitant-palonosetron) plus dexamethasone with other NK1 antagonist-based regimens combined with a 5HT3 receptor antagonist and dexamethasone is crucial for informed decision-making and improving patient outcomes. Methods: We conducted a systematic review of the literature [...]